CHONGQING, CHINA - FEBRUARY 3: In this photo illustration, a smartphone displays the logo of Moderna, Inc. (NASDAQ: MRNA), a U.S.-based biotechnology company specializing in messenger RNA (mRNA) ...

Moderna (NasdaqGS:MRNA) has reached a global settlement with Genevant Sciences and Arbutus Biopharma over lipid nanoparticle technology used in its Covid 19 vaccines. The agreement includes a ...

Yahoo Finance Markets and Data Editor Jared Blikre and Market Catalysts host Julie Hyman take a closer look at some of Tuesday morning's trending tickers and stories. Kohl's (KSS) stock is moving ...

A man used ChatGPT to cure his dog. Here are the stocks for the new age of programmable medicine. Pet owner Paul Conyngham (second right) and Professor Pall Thordarson discussed the cancer vaccine ...

Generate Biomedicines IPO highlights AI-driven drug discovery, strong backing, promising pipeline, and investor confidence signals.

Both Bank of America and JPMorgan are hosting conferences on the industrial sector, featuring presentations from companies including Boeing (BA) and American Airlines (AAL). Delta Air Lines (DAL) ...

Merck MRK continues to face challenges with its second-largest product, Gardasil, which is a vaccine approved to prevent certain cancers caused by the human papillomavirus. While the vaccine’s sales ...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer ...

His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial intelligence (AI). He is applying this to transferring as much of the load as ...

They aren't just "pandemic stocks." ...